152 related articles for article (PubMed ID: 15569627)
21. Suppression of xenobiotic-metabolizing enzyme expression in rats by acriflavine, a protein kinase C inhibitor. Effects on epoxide hydrolase, glutathione S-transferases, and cytochromes p450.
Kim SG; Cho JY; Chung YS; Ahn ET; Lee KY; Han YB
Drug Metab Dispos; 1998 Jan; 26(1):66-72. PubMed ID: 9443855
[TBL] [Abstract][Full Text] [Related]
22. Evidence for a complex formation between CYP2J5 and mEH in living cells by FRET analysis of membrane protein interaction in the endoplasmic reticulum (FAMPIR).
Orjuela Leon AC; Marwosky A; Arand M
Arch Toxicol; 2017 Nov; 91(11):3561-3570. PubMed ID: 29030652
[TBL] [Abstract][Full Text] [Related]
23. Comparative effects of flavonoids and model inducers on drug-metabolizing enzymes in rat liver.
Canivenc-Lavier MC; Vernevaut MF; Totis M; Siess MH; Magdalou J; Suschetet M
Toxicology; 1996 Nov; 114(1):19-27. PubMed ID: 8931757
[TBL] [Abstract][Full Text] [Related]
24. Absolute quantification and differential expression of drug transporters, cytochrome P450 enzymes, and UDP-glucuronosyltransferases in cultured primary human hepatocytes.
Schaefer O; Ohtsuki S; Kawakami H; Inoue T; Liehner S; Saito A; Sakamoto A; Ishiguro N; Matsumaru T; Terasaki T; Ebner T
Drug Metab Dispos; 2012 Jan; 40(1):93-103. PubMed ID: 21979928
[TBL] [Abstract][Full Text] [Related]
25. Challenges and Opportunities with Non-CYP Enzymes Aldehyde Oxidase, Carboxylesterase, and UDP-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance.
Argikar UA; Potter PM; Hutzler JM; Marathe PH
AAPS J; 2016 Nov; 18(6):1391-1405. PubMed ID: 27495117
[TBL] [Abstract][Full Text] [Related]
26. Expression of human cytochromes P450 1A1 and P450 1A2 as fused enzymes with yeast NADPH-cytochrome P450 oxidoreductase in transgenic tobacco plants.
Shiota N; Kodama S; Inui H; Ohkawa H
Biosci Biotechnol Biochem; 2000 Oct; 64(10):2025-33. PubMed ID: 11129571
[TBL] [Abstract][Full Text] [Related]
27. Direct comparison of UDP-glucuronosyltransferase and cytochrome P450 activities in human liver microsomes, plated and suspended primary human hepatocytes from five liver donors.
den Braver-Sewradj SP; den Braver MW; Baze A; Decorde J; Fonsi M; Bachellier P; Vermeulen NPE; Commandeur JNM; Richert L; Vos JC
Eur J Pharm Sci; 2017 Nov; 109():96-110. PubMed ID: 28778465
[TBL] [Abstract][Full Text] [Related]
28. Predicting reactivity to drug metabolism: beyond P450s-modelling FMOs and UGTs.
Öeren M; Walton PJ; Hunt PA; Ponting DJ; Segall MD
J Comput Aided Mol Des; 2021 Apr; 35(4):541-555. PubMed ID: 32533369
[TBL] [Abstract][Full Text] [Related]
29. A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development.
Oda S; Fukami T; Yokoi T; Nakajima M
Drug Metab Pharmacokinet; 2015 Feb; 30(1):30-51. PubMed ID: 25760529
[TBL] [Abstract][Full Text] [Related]
30. Characterization and profiling of hepatic cytochromes P450 and phase II xenobiotic-metabolizing enzymes in beluga whales (Delphinapterus leucas) from the St. Lawrence River Estuary and the Canadian Arctic.
McKinney MA; Arukwe A; De Guise S; Martineau D; Béland P; Dallaire A; Lair S; Lebeuf M; Letcher RJ
Aquat Toxicol; 2004 Jul; 69(1):35-49. PubMed ID: 15210296
[TBL] [Abstract][Full Text] [Related]
31. Drug-metabolizing enzymes in the skin of man, rat, and pig.
Oesch F; Fabian E; Oesch-Bartlomowicz B; Werner C; Landsiedel R
Drug Metab Rev; 2007; 39(4):659-98. PubMed ID: 18058329
[TBL] [Abstract][Full Text] [Related]
32. Modulation of UDP-glucuronosyltransferase function by cytochrome P450: evidence for the alteration of UGT2B7-catalyzed glucuronidation of morphine by CYP3A4.
Takeda S; Ishii Y; Iwanaga M; Mackenzie PI; Nagata K; Yamazoe Y; Oguri K; Yamada H
Mol Pharmacol; 2005 Mar; 67(3):665-72. PubMed ID: 15611481
[TBL] [Abstract][Full Text] [Related]
33. The potential impact of CYP and UGT drug-metabolizing enzymes on brain target site drug exposure.
Zhang M; Rottschäfer V; C M de Lange E
Drug Metab Rev; 2024 Feb; 56(1):1-30. PubMed ID: 38126313
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities.
Ohtsuki S; Schaefer O; Kawakami H; Inoue T; Liehner S; Saito A; Ishiguro N; Kishimoto W; Ludwig-Schwellinger E; Ebner T; Terasaki T
Drug Metab Dispos; 2012 Jan; 40(1):83-92. PubMed ID: 21994437
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous Screening of Activities of Five Cytochrome P450 and Four Uridine 5'-Diphospho-glucuronosyltransferase Enzymes in Human Liver Microsomes Using Cocktail Incubation and Liquid Chromatography-Tandem Mass Spectrometry.
Lee B; Ji HK; Lee T; Liu KH
Drug Metab Dispos; 2015 Jul; 43(7):1137-46. PubMed ID: 25904760
[TBL] [Abstract][Full Text] [Related]
36. Effects of 5-fluorouracil on the drug-metabolizing enzymes of the small intestine and the consequent drug interaction with nifedipine in rats.
Yoshisue K; Nagayama S; Shindo T; Kawaguchi Y
J Pharmacol Exp Ther; 2001 Jun; 297(3):1166-75. PubMed ID: 11356943
[TBL] [Abstract][Full Text] [Related]
37. Human cytochrome P450 isozymes in metabolism and health effects of gasoline ethers.
Hong JY; Wang YY; Mohr SN; Bondoc FY; Deng C
Res Rep Health Eff Inst; 2001 May; (102):7-27; discussion 95-109. PubMed ID: 11504148
[TBL] [Abstract][Full Text] [Related]
38. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes.
Ahn D; Putt D; Kresty L; Stoner GD; Fromm D; Hollenberg PF
Carcinogenesis; 1996 Apr; 17(4):821-8. PubMed ID: 8625497
[TBL] [Abstract][Full Text] [Related]
39. Expression of cytochrome P450s and microsomal epoxide hydrolase in primary cultures of human umbilical vein endothelial cells.
Farin FM; Pohlman TH; Omiecinski CJ
Toxicol Appl Pharmacol; 1994 Jan; 124(1):1-9. PubMed ID: 7507267
[TBL] [Abstract][Full Text] [Related]
40. Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b(5) enzymes.
Shimada T; Mernaugh RL; Guengerich FP
Arch Biochem Biophys; 2005 Mar; 435(1):207-16. PubMed ID: 15680923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]